Members of the CD1 family are key players in the immune response to glycolipids and may be involved in the GBS pathogenesis, especially in patients with history of C.jejuni infections and antiganglioside antibodies (Caporale et al., 2006; De Libero et al., 2005). Here, CD1A is linked to Guillain-Barre syndrome.